Characteristics, outcomes, and risk factors of surgery for acute lower gastrointestinal bleeding: nationwide cohort study of 10,342 hematochezia cases
Jun Omori,Mitsuru Kaise,Naoyoshi Nagata,Tomonori Aoki,Katsumasa Kobayashi,Atsushi Yamauchi,Atsuo Yamada,Takashi Ikeya,Taiki Aoyama,Naoyuki Tominaga,Yoshinori Sato,Takaaki Kishino,Naoki Ishii,Tsunaki Sawada,Masaki Murata,Akinari Takao,Kazuhiro Mizukami,Ken Kinjo,Shunji Fujimori,Takahiro Uotani,Minoru Fujita,Hiroki Sato,Sho Suzuki,Toshiaki Narasaka,Junnosuke Hayasaka,Tomohiro Funabiki,Yuzuru Kinjo,Akira Mizuki,Shu Kiyotoki,Tatsuya Mikami,Ryosuke Gushima,Hiroyuki Fujii,Yuta Fuyuno,Takuto Hikichi,Yosuke Toya,Kazuyuki Narimatsu,Noriaki Manabe,Koji Nagaike,Tetsu Kinjo,Yorinobu Sumida,Sadahiro Funakoshi,Kiyonori Kobayashi,Tamotsu Matsuhashi,Yuga Komaki,Kuniko Miki,Kazuhiro Watanabe,Katsuhiko Iwakiri
DOI: https://doi.org/10.1007/s00535-023-02057-9
Abstract:Background: Current evidence on the surgical rate, indication, procedure, risk factors, mortality, and postoperative rebleeding for acute lower gastrointestinal bleeding (ALGIB) is limited. Methods: We constructed a retrospective cohort of 10,342 patients admitted for acute hematochezia at 49 hospitals (CODE BLUE J-Study) and evaluated clinical data on the surgeries performed. Results: Surgery was performed in 1.3% (136/10342) of the cohort with high rates of colonoscopy (87.7%) and endoscopic hemostasis (26.7%). Indications for surgery included colonic diverticular bleeding (24%), colorectal cancer (22%), and small bowel bleeding (16%). Sixty-four percent of surgeries were for hemostasis for severe refractory bleeding. Postoperative rebleeding rates were 22% in patients with presumptive or obscure preoperative identification of the bleeding source and 12% in those with definitive identification. Thirty-day mortality rates were 1.5% and 0.8% in patients with and without surgery, respectively. Multivariate analysis showed that surgery-related risk factors were transfusion need ≥ 6 units (P < 0.001), in-hospital rebleeding (P < 0.001), small bowel bleeding (P < 0.001), colorectal cancer (P < 0.001), and hemorrhoids (P < 0.001). Endoscopic hemostasis was negatively associated with surgery (P = 0.003). For small bowel bleeding, the surgery rate was significantly lower in patients with endoscopic hemostasis as 2% compared to 12% without endoscopic hemostasis. Conclusions: Our cohort study elucidated the outcomes and risks of the surgery. Extensive exploration including the small bowel to identify the source of bleeding and endoscopic hemostasis may reduce unnecessary surgery and improve the management of ALGIB.